Stereotactic Radiosurgery for Brain Metastases from Lung Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of the study is to see if stereotactic radiosurgery/SRS is an effective treatment for people with a new diagnosis of brain metastases from small cell lung cancer/SCLC.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is stereotactic radiosurgery (SRS) safe for humans?
How does the treatment Stereotactic Radiosurgery (SRS) for brain metastases from lung cancer differ from other treatments?
Stereotactic Radiosurgery (SRS) is unique because it delivers a highly focused, single session of radiation directly to the brain metastases, minimizing exposure to surrounding healthy tissue. This approach reduces the need for invasive surgery and avoids the broader side effects associated with whole brain radiation therapy.678910
What data supports the effectiveness of the treatment Stereotactic Radiosurgery for brain metastases from lung cancer?
Research shows that Stereotactic Radiosurgery (SRS) is effective in prolonging survival for patients with a single brain metastasis and maintaining functional independence for those with up to three brain metastases. It is a precise treatment option that has become standard for patients with few metastatic brain lesions, offering an alternative to whole brain radiation therapy.68111213
Who Is on the Research Team?
Luke Pike, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
This trial is for adults with small cell lung cancer that has spread to the brain. They must be able to consent, have a good performance status (able to carry out daily activities), and women must not be pregnant. People can't join if they've had previous brain radiotherapy, are pregnant or breastfeeding, can't undergo MRI scans, or have uncontrolled systemic disease.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive stereotactic radiosurgery (SRS) for brain metastases from small cell lung cancer
Follow-up
Participants are monitored for overall survival and effectiveness of the treatment
What Are the Treatments Tested in This Trial?
Interventions
- Stereotactic Radiosurgery
Stereotactic Radiosurgery is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor